Difficulty: Medium
Average Score: 68%
Practice
A patient with chronic lymphocytic leukemia (CLL) is at risk for tumor lysis syndrome. What laboratory values should the nurse monitor to detect this complication?
Correct answer
B
Rationale
In the context of pharmacology and oncology, understanding the potential complications of certain conditions like tumor lysis syndrome is crucial for nurses and healthcare providers. In this scenario, the correct answer is option B) Electrolytes and uric acid levels.
Tumor lysis syndrome is a potential complication in patients with CLL undergoing treatment, where rapid destruction of cancer cells releases their contents into the bloodstream, leading to metabolic imbalances. Monitoring electrolyte levels, such as potassium, phosphorus, and calcium, is essential to detect any abnormalities that may arise due to tumor lysis.
The other options are incorrect because they do not directly relate to the metabolic changes associated with tumor lysis syndrome. Creatinine and BUN (option A) are markers of kidney function, serum glucose and calcium levels (option C) are important for different reasons, and liver enzymes and bilirubin levels (option D) are more indicative of liver function and not specific to tumor lysis syndrome.
In an educational context, understanding the rationale behind monitoring specific laboratory values in different clinical situations is vital for providing safe and effective patient care. By knowing which parameters to assess, nurses can promptly identify complications like tumor lysis syndrome and take appropriate actions to manage them, ultimately improving patient outcomes.
Tumor lysis syndrome is a potential complication in patients with CLL undergoing treatment, where rapid destruction of cancer cells releases their contents into the bloodstream, leading to metabolic imbalances. Monitoring electrolyte levels, such as potassium, phosphorus, and calcium, is essential to detect any abnormalities that may arise due to tumor lysis.
The other options are incorrect because they do not directly relate to the metabolic changes associated with tumor lysis syndrome. Creatinine and BUN (option A) are markers of kidney function, serum glucose and calcium levels (option C) are important for different reasons, and liver enzymes and bilirubin levels (option D) are more indicative of liver function and not specific to tumor lysis syndrome.
In an educational context, understanding the rationale behind monitoring specific laboratory values in different clinical situations is vital for providing safe and effective patient care. By knowing which parameters to assess, nurses can promptly identify complications like tumor lysis syndrome and take appropriate actions to manage them, ultimately improving patient outcomes.